Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation

20260 citationsJournal Articlegold Open Access

Authors

Helton Jose Reis · Universidade Federal de Minas Gerais

Luana Bernardes Xavier Costa · Universidade Federal de Minas Gerais

Gabriela Lopes Martins · Universidade Federal de Minas Gerais

Rita Carolina Figueiredo Duarte · Universidade Federal de Minas Gerais

Luma Clara Martins Costa · Universidade Federal de Minas Gerais

Estêvão Lanna Figueiredo · Lifecenter Hospital

Francisco Rezende Silveira

Abstract

These results suggest that in patients with AF, rivaroxaban may provide pleiotropic benefits beyond anticoagulation, potentially by augmenting cellular antioxidant mechanisms and suppressing antifibrinolytic activity.

Topics & Keywords

Atrial Fibrillation Management and Outcomes Vitamin K Research Studies Blood properties and coagulation

Publication Details

Published in: Frontiers in Pharmacology

Volume 17, pp. 1685101-1685101

DOI: 10.3389/fphar.2026.1685101

Field-Weighted Citation Impact: 0.00

Command Palette

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation

Authors

Abstract

Topics & Keywords

Publication Details